678 related articles for article (PubMed ID: 22928729)
21. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
Oosterhuis I; van Hunsel FP; van Puijenbroek EP
Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
[TBL] [Abstract][Full Text] [Related]
22. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
23. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
[TBL] [Abstract][Full Text] [Related]
24. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
25. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
[TBL] [Abstract][Full Text] [Related]
26. The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK.
Klein K; Hazell L; Stolk P; Shakir S
Drug Saf; 2020 Mar; 43(3):255-263. PubMed ID: 31872358
[TBL] [Abstract][Full Text] [Related]
27. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
Castillon G; Salvo F; Moride Y
Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
[TBL] [Abstract][Full Text] [Related]
28. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
van Hunsel F; de Waal S; Härmark L
Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293
[TBL] [Abstract][Full Text] [Related]
29. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
Aagaard L; Nielsen LH; Hansen EH
Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778
[TBL] [Abstract][Full Text] [Related]
30. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017.
Steyn H
S Afr Med J; 2023 Jun; 113(6):26-33. PubMed ID: 37278262
[TBL] [Abstract][Full Text] [Related]
31. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.
Rehan HS; Chopra D; Holani SN; Mishra R
Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346
[TBL] [Abstract][Full Text] [Related]
32. Performance of probabilistic method to detect duplicate individual case safety reports.
Tregunno PM; Fink DB; Fernandez-Fernandez C; Lázaro-Bengoa E; Norén GN
Drug Saf; 2014 Apr; 37(4):249-58. PubMed ID: 24627310
[TBL] [Abstract][Full Text] [Related]
33. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.
Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G
Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583
[TBL] [Abstract][Full Text] [Related]
34. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
[TBL] [Abstract][Full Text] [Related]
35. Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.
Getova VI; Georgiev SR; Stoimenova AH; Petkova-Georgieva ES
Folia Med (Plovdiv); 2018 Sep; 60(3):447-453. PubMed ID: 30355838
[TBL] [Abstract][Full Text] [Related]
36. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
Herdeiro MT; Ribeiro-Vaz I; Ferreira M; Polónia J; Falcão A; Figueiras A
Drug Saf; 2012 Aug; 35(8):655-65. PubMed ID: 22788235
[TBL] [Abstract][Full Text] [Related]
37. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
Johansson ML; Hägg S; Wallerstedt SM
BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
[TBL] [Abstract][Full Text] [Related]
38. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
[TBL] [Abstract][Full Text] [Related]
39. Improving the data quality of spontaneous ADR reports: a practical example from Malta.
Zuccarelli M; Micallef B; Butler D; Serracino-Inglott A; Borg JJ
Expert Opin Drug Saf; 2022 Feb; 21(2):253-268. PubMed ID: 34649475
[TBL] [Abstract][Full Text] [Related]
40. Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study.
Monteiro C; Dias B; Vaz-Patto M
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33799926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]